Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Accidental hexylresorcinol poisoning |
Causative agent (attribute) |
False |
Hexylresorcinol |
Inferred relationship |
Some |
|
Intentional hexylresorcinol poisoning |
Causative agent (attribute) |
False |
Hexylresorcinol |
Inferred relationship |
Some |
|
intoxication par l'hexylrésorcinol d'intention indéterminée |
Causative agent (attribute) |
False |
Hexylresorcinol |
Inferred relationship |
Some |
1 |
Poisoning by hexylresorcinol |
Causative agent (attribute) |
True |
Hexylresorcinol |
Inferred relationship |
Some |
1 |
Product containing hexylresorcinol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hexylresorcinol |
Inferred relationship |
Some |
1 |
Accidental hexylresorcinol poisoning |
Causative agent (attribute) |
True |
Hexylresorcinol |
Inferred relationship |
Some |
1 |
Intentional hexylresorcinol poisoning |
Causative agent (attribute) |
True |
Hexylresorcinol |
Inferred relationship |
Some |
1 |
Adverse reaction to hexylresorcinol |
Causative agent (attribute) |
True |
Hexylresorcinol |
Inferred relationship |
Some |
1 |
Product containing benzalkonium and hexylresorcinol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hexylresorcinol |
Inferred relationship |
Some |
2 |
Benzalkonium and hexylresorcinol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hexylresorcinol |
Inferred relationship |
Some |
2 |
Product containing only hexylresorcinol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hexylresorcinol |
Inferred relationship |
Some |
1 |
Product containing precisely hexylresorcinol 2.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Hexylresorcinol |
Inferred relationship |
Some |
1 |
Product containing precisely hexylresorcinol 2.4 milligram/1 each conventional release oromucosal lozenge (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Hexylresorcinol |
Inferred relationship |
Some |
1 |
Product containing only hexylresorcinol in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hexylresorcinol |
Inferred relationship |
Some |
1 |
Hexylresorcinol-containing product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hexylresorcinol |
Inferred relationship |
Some |
1 |